New Market Research Report: Canada Pharmaceuticals & Healthcare Report Q3 2014
BMI View: We highlight further downside risk to the Canadian construction sector in the near term, and thus place risks to the downside to our view for 2% real growth in 2014. Whilst weakness in the residential sector has been priced in, we could see scope for a more abrupt slowdown in infrastructure industry value growth as we reach the latter end of the cycle for major projects, and do not expect the positive impact of the CAD53bn New Building...
View full press release